33
views
0
recommends
+1 Recommend
1 collections
    4
    shares

      To submit to Bentham Journals, please click here

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Influence of Severe Carotid Stenosis on Cognition, Depressive Symptoms and Quality of Life

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background:

          Carotid artery disease is not just a causal risk factor of ischemic stroke, but may predispose patients to depressive symptoms and low health related quality of life (HRQoL).

          Objectives:

          The objectives of the present study were to assess the association between severe carotid artery stenosis (CAS) and cognitive impairment, frequency of depressive symptoms and status of HRQoL.

          Methods:

          Cross - sectional study involved 55 patients with severe CAS and 54 patients with lower extremity peripheral artery disease (PAD). Cognitive impairment was assessed using Montreal Cognitive Assessment Scale (MoCA), depressive symptoms - PHQ-9 scale. HRQoL was measured using Medical Outcome Survey Short Form version 2 (SF-36v2).

          Results:

          Median MoCA score 24 [23;26] was significantly lower in patients with severe CAS than in patients with PAD - 26 [25-28],( p=0.005; effect size r=0.3). There was no statistically significant difference of median PHQ-9 scores the in CAS group (median PHQ-9 score 4.0 [5]) and in the PAD group (median PHQ-9 score 5.5 [7]), ( p=0.08, effect size r=0.18). Mean SF-36v2 scores were similar in CAS and PAD groups except for bodily pain ( p=0.001, Cohen's d value = 0.77) and vitality ( p=0.02, Cohen's d value = 0.49).

          Conclusion:

          In summary, our findings indicate that severe CAS could play a role in cognitive decline. Further studies should be conducted using larger patient cohorts without ischemic brain lesions and with balanced vascular risk profiles to investigate impact of CAS on cognition. There was no association between severe CAS and depressive symptoms in the present study. As patients with severe CAS did not exhibit physical symptoms, HRQoL was better for those patients than for patients with lower extremity PAD.

          Related collections

          Most cited references47

          • Record: found
          • Abstract: found
          • Article: not found

          The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review.

          Depression, anxiety and somatization are the most common mental disorders in primary care as well as medical specialty populations; each is present in at least 5-10% of patients and frequently comorbid with one another. An efficient means for measuring and monitoring all three conditions would be desirable. Evidence regarding the psychometric and pragmatic characteristics of the Patient Health Questionnaire (PHQ)-9 depression, generalized anxiety disorder (GAD)-7 anxiety and PHQ-15 somatic symptom scales are synthesized from two sources: (1) four multisite cross-sectional studies (three conducted in primary care and one in obstetric-gynecology practices) comprising 9740 patients, and (2) key studies from the literature that have studied these scales. The PHQ-9 and its abbreviated eight-item (PHQ-8) and two-item (PHQ-2) versions have good sensitivity and specificity for detecting depressive disorders. Likewise, the GAD-7 and its abbreviated two-item (GAD-2) version have good operating characteristics for detecting generalized anxiety, panic, social anxiety and post-traumatic stress disorder. The optimal cutpoint is > or = 10 on the parent scales (PHQ-9 and GAD-7) and > or = 3 on the ultra-brief versions (PHQ-2 and GAD-2). The PHQ-15 is equal or superior to other brief measures for assessing somatic symptoms and screening for somatoform disorders. Cutpoints of 5, 10 and 15 represent mild, moderate and severe symptom levels on all three scales. Sensitivity to change is well-established for the PHQ-9 and emerging albeit not yet definitive for the GAD-7 and PHQ-15. The PHQ-9, GAD-7 and PHQ-15 are brief well-validated measures for detecting and monitoring depression, anxiety and somatization. Copyright 2010. Published by Elsevier Inc.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Endarterectomy for Asymptomatic Carotid Artery Stenosis

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Vascular Cognitive Impairment.

              Cerebrovascular disease typically manifests with stroke, cognitive impairment, or both. Vascular cognitive impairment refers to all forms of cognitive disorder associated with cerebrovascular disease, regardless of the specific mechanisms involved. It encompasses the full range of cognitive deficits from mild cognitive impairment to dementia. In principle, any of the multiple causes of clinical stroke can cause vascular cognitive impairment. Recent work further highlights a role of microinfarcts, microhemorrhages, strategic white matter tracts, loss of microstructural tissue integrity, and secondary neurodegeneration. Vascular brain injury results in loss of structural and functional connectivity and, hence, compromise of functional networks within the brain. Vascular cognitive impairment is common both after stroke and in stroke-free individuals presenting to dementia clinics, and vascular pathology frequently coexists with neurodegenerative pathology, resulting in mixed forms of mild cognitive impairment or dementia. Vascular dementia is now recognized as the second most common form of dementia after Alzheimer's disease, and there is increasing awareness that targeting vascular risk may help to prevent dementia, even of the Alzheimer type. Recent advances in neuroimaging, neuropathology, epidemiology, and genetics have led to a deeper understanding of how vascular disease affects cognition. These new findings provide an opportunity for the present reappraisal of vascular cognitive impairment. We further briefly address current therapeutic concepts.
                Bookmark

                Author and article information

                Journal
                Clin Pract Epidemiol Ment Health
                Clin Pract Epidemiol Ment Health
                CPEMH
                Clinical Practice and Epidemiology in Mental Health : CP & EMH
                Bentham Open
                1745-0179
                19 October 2017
                2017
                : 13
                : 168-180
                Affiliations
                [1 ]Department of Neurology, Pauls Stradins Clinical University Hospital, , Latvia
                [2 ]Department of Neurology and Neurosurgery, Riga Stradins University, Riga, Latvia
                [3 ]Department of Physics, Riga Stradins University, , Latvia
                [4 ]Vascular Surgery Centre, Pauls Stradins Clinical University Hospital, , Latvia
                [5 ]Department of Surgery, University of Latvia, Faculty of Medicine, , Latvia
                Author notes
                [* ]Address of the corresponding author the Riga Stradins University, Department of Neurology and Neurosurgery, Pilsonu Street 13, LV 1002, Riga, Latvia, Tel: +371 67069219; E-mail: elina.pucite@ 123456rsu.lv
                Article
                CPEMH-13-168
                10.2174/1745017901713010168
                5712638
                29238393
                39e276e4-effe-4692-97e0-0cf3e45f6676
                © 2017 Pucite et al.

                This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                : 8 August 2017
                : 7 September 2017
                : 26 September 2017
                Categories
                Article

                Neurology
                carotid stenosis,cognitive impairment,depressive symptoms,quality of life,ischemic stroke,low health

                Comments

                Comment on this article